51 related articles for article (PubMed ID: 14693739)
1. Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.
Giovannini S; Cesari M; Marzetti E; Leeuwenburgh C; Maggio M; Pahor M
J Nutr Health Aging; 2010 Jun; 14(6):457-60. PubMed ID: 20617288
[TBL] [Abstract][Full Text] [Related]
2. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.
Macis D; Gandini S; Guerrieri-Gonzaga A; Johansson H; Magni P; Ruscica M; Lazzeroni M; Serrano D; Cazzaniga M; Mora S; Feroce I; Pizzamiglio M; Sandri MT; Gulisano M; Bonanni B; Decensi A
J Clin Oncol; 2012 Jan; 30(2):151-7. PubMed ID: 22162577
[TBL] [Abstract][Full Text] [Related]
3. Reduction in Ki-67 in benign breast tissue of high-risk women with the lignan secoisolariciresinol diglycoside.
Fabian CJ; Kimler BF; Zalles CM; Klemp JR; Petroff BK; Khan QJ; Sharma P; Setchell KD; Zhao X; Phillips TA; Metheny T; Hughes JR; Yeh HW; Johnson KA
Cancer Prev Res (Phila); 2010 Oct; 3(10):1342-50. PubMed ID: 20724470
[TBL] [Abstract][Full Text] [Related]
4. Fenretinide in young women at genetic or familial risk of breast cancer: A placebo-controlled biomarker trial.
Aristarco V; Serrano D; Maisonneuve P; Guerrieri-Gonzaga A; Lazzeroni M; Feroce I; Macis D; Cavadini E; Albertazzi E; Jemos C; Omodeo Salè E; Cortesi L; Massarut S; Gulisano M; Daidone MG; Johansson H; Bonanni B
Cancer Prev Res (Phila); 2024 Mar; ():. PubMed ID: 38530139
[TBL] [Abstract][Full Text] [Related]
5. Estrogens and selective estrogen receptor modulators in acromegaly.
Duarte FH; Jallad RS; Bronstein MD
Endocrine; 2016 Nov; 54(2):306-314. PubMed ID: 27704479
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene: a review of its use in the prevention of invasive breast cancer.
Moen MD; Keating GM
Drugs; 2008; 68(14):2059-83. PubMed ID: 18778124
[TBL] [Abstract][Full Text] [Related]
7. Effect of raloxifene on mammographic density and breast magnetic resonance imaging in premenopausal women at increased risk for breast cancer.
Eng-Wong J; Orzano-Birgani J; Chow CK; Venzon D; Yao J; Galbo CE; Zujewski JA; Prindiville S
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1696-701. PubMed ID: 18583470
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene.
da Silva BB; Moita DS; Pires CG; Sousa-Junior EC; dos Santos AR; Lopes-Costa PV
Int Semin Surg Oncol; 2007 Jul; 4():18. PubMed ID: 17645796
[TBL] [Abstract][Full Text] [Related]
9. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
10. Conjugated estrogens and breast cancer risk.
Campagnoli C; Ambroggio S; Biglia N; Sismondi P
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():13-9. PubMed ID: 10862264
[TBL] [Abstract][Full Text] [Related]
11. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
13. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
[TBL] [Abstract][Full Text] [Related]
14. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer.
Decensi A; Johansson H; Miceli R; Mariani L; Camerini T; Cavadini E; Di Mauro MG; Barreca A; Gonzaga AG; Diani S; Sandri MT; De Palo G; Formelli F
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1047-53. PubMed ID: 11588130
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
